Correlation
The correlation between RNA and STRO is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
RNA vs. STRO
Compare and contrast key facts about Avidity Biosciences, Inc. (RNA) and Sutro Biopharma, Inc. (STRO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RNA or STRO.
Performance
RNA vs. STRO - Performance Comparison
Loading data...
Key characteristics
RNA:
0.20
STRO:
-0.66
RNA:
0.91
STRO:
-1.05
RNA:
1.11
STRO:
0.87
RNA:
0.33
STRO:
-0.80
RNA:
0.59
STRO:
-1.46
RNA:
29.76%
STRO:
53.69%
RNA:
72.87%
STRO:
120.00%
RNA:
-86.45%
STRO:
-98.10%
RNA:
-40.99%
STRO:
-96.74%
Fundamentals
RNA:
$3.73B
STRO:
$76.02M
RNA:
-$3.00
STRO:
-$2.91
RNA:
418.25
STRO:
1.14
RNA:
2.81
STRO:
2.11
RNA:
$8.93M
STRO:
$66.43M
RNA:
$5.93M
STRO:
$2.55M
RNA:
-$431.82M
STRO:
-$200.97M
Returns By Period
In the year-to-date period, RNA achieves a 6.53% return, which is significantly higher than STRO's -51.21% return.
RNA
6.53%
-5.23%
-28.00%
15.34%
30.53%
N/A
N/A
STRO
-51.21%
-16.10%
-66.12%
-78.75%
-40.91%
-38.26%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RNA vs. STRO — Risk-Adjusted Performance Rank
RNA
STRO
RNA vs. STRO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Avidity Biosciences, Inc. (RNA) and Sutro Biopharma, Inc. (STRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RNA vs. STRO - Dividend Comparison
Neither RNA nor STRO has paid dividends to shareholders.
Drawdowns
RNA vs. STRO - Drawdown Comparison
The maximum RNA drawdown since its inception was -86.45%, smaller than the maximum STRO drawdown of -98.10%. Use the drawdown chart below to compare losses from any high point for RNA and STRO.
Loading data...
Volatility
RNA vs. STRO - Volatility Comparison
The current volatility for Avidity Biosciences, Inc. (RNA) is 26.12%, while Sutro Biopharma, Inc. (STRO) has a volatility of 30.54%. This indicates that RNA experiences smaller price fluctuations and is considered to be less risky than STRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RNA vs. STRO - Financials Comparison
This section allows you to compare key financial metrics between Avidity Biosciences, Inc. and Sutro Biopharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities